ERSAI Trademark

Trademark Overview


On Monday, November 29, 2021, a trademark application was filed for ERSAI with the United States Patent and Trademark Office. The USPTO has given the ERSAI trademark a serial number of 97145951. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, September 10, 2024. This trademark is owned by Dewpoint Therapeutics, Inc.. The ERSAI trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:

Downloadable computer software using artificial intelligence for software development, machine learning, integrated databases and workflow processes in the field of scientific research and drug discovery

Scientific condensate-based research in the field of drug discovery and drug development; providing online, non-downloadable computer software using artificial intelligence for software development, machine learning, integrated databases and workflow processes in the field of scientific research and drug discovery; online, non-downloadable computer software using artificial intelligence for software development, machine learning, integrated databases and workflow processes in the field of scientific research and drug discovery
ersai

General Information


Serial Number97145951
Word MarkERSAI
Filing DateMonday, November 29, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, September 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements


Goods and ServicesDownloadable computer software using artificial intelligence for software development, machine learning, integrated databases and workflow processes in the field of scientific research and drug discovery
Goods and ServicesScientific condensate-based research in the field of drug discovery and drug development; providing online, non-downloadable computer software using artificial intelligence for software development, machine learning, integrated databases and workflow processes in the field of scientific research and drug discovery; online, non-downloadable computer software using artificial intelligence for software development, machine learning, integrated databases and workflow processes in the field of scientific research and drug discovery

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateTuesday, November 29, 2022
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 2, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDewpoint Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Party NameDewpoint Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Thursday, December 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 21, 2022ASSIGNED TO EXAMINER
Wednesday, June 22, 2022NON-FINAL ACTION WRITTEN
Wednesday, June 22, 2022NON-FINAL ACTION E-MAILED
Wednesday, June 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 29, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 29, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 29, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 13, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, February 14, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, February 16, 2023NON-FINAL ACTION WRITTEN
Thursday, February 16, 2023NON-FINAL ACTION E-MAILED
Thursday, February 16, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, September 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 8, 2024SOU EXTENSION 1 FILED
Friday, March 8, 2024SOU EXTENSION 1 GRANTED
Friday, March 8, 2024SOU TEAS EXTENSION RECEIVED
Saturday, March 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 10, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 10, 2024SOU EXTENSION 2 FILED
Tuesday, September 10, 2024SOU EXTENSION 2 GRANTED